SNIPR BIOME Initiates First-in-Human Clinical Trial with SNIPR001

/PRNewswire/ -- SNIPR BIOME ApS, a leading CRISPR and microbiome gene therapy biotechnology company, today announced dosing of the first human subjects in its...

Related Keywords

Germany ,Denmark ,Copenhagen ,Køavn ,United Kingdom ,Munich ,Bayern ,Texas ,United States ,Amsterdam ,Noord Holland ,Netherlands , ,Boston University School Of Law ,National Institute Of Allergy ,University Of Texas Md Anderson Cancer ,Melinda Gates Foundation ,North East Family Office Copenhagen ,Wellcome ,Us Department Of Health ,United Kingdom Department Of Health ,Care Global Antimicrobial Resistance Innovation Fund ,Biomedical Advanced Research ,Human Services ,Boston University ,Development Authority ,Germany Federal Ministry Of Education ,United Kingdom Government Department Of Health ,Office Of The ,Life Sciences Partners Amsterdam ,Us National Institutes Of Health ,Novo Nordisk ,Agreement Number ,Milan Zdravkovic ,Chief Medical Officer ,Life Sciences Partners ,North East Family Office ,Wellington Partners ,Assistant Secretary ,Wellcome Trust ,Federal Ministry ,United Kingdom Department ,Social Care ,Global Antimicrobial Resistance Innovation Fund ,United Kingdom Government Department ,National Institute ,Infectious Diseases ,Resistant Threats ,Priority Bacterial Pathogens ,Boston University School ,Cooperative Agreement Number ,Snipr Biome Aps ,